Name | Number of supported studies | Average coverage | |
---|---|---|---|
GABAergic amacrine cell | 3 studies | 45% ± 14% | |
glycinergic amacrine cell | 3 studies | 54% ± 17% |
Insufficient scRNA-seq data for expression of CPLX3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
spleen | 100% | 22530.13 | 241 / 241 | 0% | 0 | 0 / 0 |
prostate | 95% | 21028.88 | 232 / 245 | 0% | 0 | 0 / 502 |
adrenal gland | 83% | 954.42 | 214 / 258 | 1% | 0.00 | 2 / 230 |
heart | 84% | 3362.94 | 720 / 861 | 0% | 0 | 0 / 0 |
brain | 74% | 2209.70 | 1948 / 2642 | 0% | 0.00 | 1 / 705 |
stomach | 42% | 2845.89 | 151 / 359 | 0% | 0.00 | 1 / 286 |
esophagus | 8% | 27.17 | 115 / 1445 | 0% | 0 | 0 / 183 |
intestine | 4% | 17.18 | 34 / 966 | 0% | 0 | 0 / 527 |
skin | 2% | 8.35 | 44 / 1809 | 0% | 0 | 0 / 472 |
breast | 2% | 18.91 | 7 / 459 | 0% | 0 | 0 / 1118 |
uterus | 1% | 6.03 | 2 / 170 | 0% | 0 | 0 / 459 |
adipose | 1% | 10.12 | 14 / 1204 | 0% | 0 | 0 / 0 |
ovary | 1% | 7.13 | 2 / 180 | 0% | 0 | 0 / 430 |
blood vessel | 1% | 8.13 | 14 / 1335 | 0% | 0 | 0 / 0 |
thymus | 1% | 2.54 | 4 / 653 | 0% | 0 | 0 / 605 |
lung | 1% | 8.65 | 3 / 578 | 0% | 0 | 0 / 1155 |
liver | 0% | 1.21 | 1 / 226 | 0% | 0 | 0 / 406 |
peripheral blood | 0% | 0.28 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bladder | 0% | 0 | 0 / 21 | 0% | 0 | 0 / 504 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 0% | 0 | 0 / 901 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
pancreas | 0% | 0 | 0 / 328 | 0% | 0 | 0 / 178 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030073 | Biological process | insulin secretion |
GO_0007601 | Biological process | visual perception |
GO_0031630 | Biological process | regulation of synaptic vesicle fusion to presynaptic active zone membrane |
GO_0016079 | Biological process | synaptic vesicle exocytosis |
GO_0046928 | Biological process | regulation of neurotransmitter secretion |
GO_0043195 | Cellular component | terminal bouton |
GO_0048787 | Cellular component | presynaptic active zone membrane |
GO_0030672 | Cellular component | synaptic vesicle membrane |
GO_0098684 | Cellular component | photoreceptor ribbon synapse |
GO_0005829 | Cellular component | cytosol |
GO_0031201 | Cellular component | SNARE complex |
GO_0005326 | Molecular function | neurotransmitter transmembrane transporter activity |
GO_0000149 | Molecular function | SNARE binding |
GO_0019905 | Molecular function | syntaxin binding |
Gene name | CPLX3 |
Protein name | Complexin-3 (Complexin III) (CPX III) |
Synonyms | Nbla11589 |
Description | FUNCTION: Complexin that regulates SNARE protein complex-mediated synaptic vesicle fusion (By similarity). Required for the maintenance of synaptic ultrastructure in the adult retina (By similarity). Positively regulates synaptic transmission through synaptic vesicle availability and exocytosis of neurotransmitters at photoreceptor ribbon synapses in the retina (By similarity). Suppresses tonic photoreceptor activity and baseline 'noise' by suppression of Ca(2+) vesicle tonic release and the facilitation of evoked synchronous and asynchronous Ca(2+) vesicle release (By similarity). . |
Accessions | Q8WVH0 ENST00000395018.6 |